EPM
ETRM

Equitec Proprietary Markets’s EnteroMedics Inc. ETRM Stock Holding History

Equitec Proprietary Markets’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,870
Closed -$74K – 136
2017
Q1 		$74K Buy
+12,870
New +$95.2K ﹤0.01% 87

Other funds holding ETRM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

Equitec Proprietary Markets's ETRM Position: Q2 2017 in Review

Equitec Proprietary Markets sold out of EnteroMedics Inc. (ETRM) in Q2 2017, closing a stake of 12,870 shares — an estimated $74K sold.

Equitec Proprietary Markets first reported a position in ETRM in Q1 2017 and held it in 1 quarter. The position peaked at $74K in Q1 2017. 16 funds tracked by Wall St. Rank hold ETRM as of Q2 2017.

  • Equitec Proprietary Markets reported no remaining EnteroMedics Inc. position as of Q2 2017 after selling out during the quarter.
  • Equitec Proprietary Markets sold 12,870 EnteroMedics Inc. shares in Q2 2017, an estimated $74K.
  • Equitec Proprietary Markets first reported a position in EnteroMedics Inc. in Q1 2017 and held it in 1 quarter.
  • Equitec Proprietary Markets's EnteroMedics Inc. position peaked at $74K in Q1 2017.
  • 16 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2017.

Based on Equitec Proprietary Markets's 13F filing for Q2 2017, filed 19 Jul 2017.